These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 18946610

  • 1. Mycophenolate mofetil in the treatment of IgA nephropathy: a systematic review.
    Tan CH, Loh PT, Yang WS, Chan CM.
    Singapore Med J; 2008 Oct; 49(10):780-5. PubMed ID: 18946610
    [Abstract] [Full Text] [Related]

  • 2. Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy: a double-blind randomized controlled trial.
    Frisch G, Lin J, Rosenstock J, Markowitz G, D'Agati V, Radhakrishnan J, Preddie D, Crew J, Valeri A, Appel G.
    Nephrol Dial Transplant; 2005 Oct; 20(10):2139-45. PubMed ID: 16030050
    [Abstract] [Full Text] [Related]

  • 3. Randomized controlled trial of mycophenolate mofetil in children, adolescents, and adults with IgA nephropathy.
    Hogg RJ, Bay RC, Jennette JC, Sibley R, Kumar S, Fervenza FC, Appel G, Cattran D, Fischer D, Hurley RM, Cerda J, Carter B, Jung B, Hernandez G, Gipson D, Wyatt RJ.
    Am J Kidney Dis; 2015 Nov; 66(5):783-91. PubMed ID: 26209543
    [Abstract] [Full Text] [Related]

  • 4. Mycophenolate mofetil treatment for IgA nephropathy: a meta-analysis.
    Xu G, Tu W, Jiang D, Xu C.
    Am J Nephrol; 2009 Nov; 29(5):362-7. PubMed ID: 18974636
    [Abstract] [Full Text] [Related]

  • 5. Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial.
    Hou JH, Le WB, Chen N, Wang WM, Liu ZS, Liu D, Chen JH, Tian J, Fu P, Hu ZX, Zeng CH, Liang SS, Zhou ML, Zhang HT, Liu ZH.
    Am J Kidney Dis; 2017 Jun; 69(6):788-795. PubMed ID: 28215945
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic review.
    Chen Y, Li Y, Yang S, Li Y, Liang M.
    BMC Nephrol; 2014 Dec 05; 15():193. PubMed ID: 25475967
    [Abstract] [Full Text] [Related]

  • 7. Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study.
    Maes BD, Oyen R, Claes K, Evenepoel P, Kuypers D, Vanwalleghem J, Van Damme B, Vanrenterghem YF.
    Kidney Int; 2004 May 05; 65(5):1842-9. PubMed ID: 15086925
    [Abstract] [Full Text] [Related]

  • 8. Treatment of Patients with IgA Nephropathy: Evaluation of the Safety and Efficacy of Mycophenolate Mofetil.
    Chen Z, Chen W, Zheng L, Xie Y, Yao K, Zhou T.
    Curr Pharm Des; 2024 May 05; 30(30):2400-2409. PubMed ID: 38988169
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial.
    Hou FF, Xie D, Wang J, Xu X, Yang X, Ai J, Nie S, Liang M, Wang G, Jia N, MAIN Trial Investigators.
    JAMA Netw Open; 2023 Feb 01; 6(2):e2254054. PubMed ID: 36745456
    [Abstract] [Full Text] [Related]

  • 10. Treatment of IgA nephropathy: corticosteroids, tonsillectomy, and mycophenolate mofetil.
    Kawamura T.
    Contrib Nephrol; 2007 Feb 01; 157():37-43. PubMed ID: 17495435
    [Abstract] [Full Text] [Related]

  • 11. Long-term study of mycophenolate mofetil treatment in IgA nephropathy.
    Tang SC, Tang AW, Wong SS, Leung JC, Ho YW, Lai KN.
    Kidney Int; 2010 Mar 01; 77(6):543-9. PubMed ID: 20032964
    [Abstract] [Full Text] [Related]

  • 12. [A randomized control trial of mycophenolate mofeil treatment in severe IgA nephropathy].
    Chen X, Chen P, Cai G, Wu J, Cui Y, Zhang Y, Liu S, Tang L.
    Zhonghua Yi Xue Za Zhi; 2002 Jun 25; 82(12):796-801. PubMed ID: 12126522
    [Abstract] [Full Text] [Related]

  • 13. [Mycophenolate mofetil in high risk IgA glomerulonephritis].
    Frutos MA, López V, Alférez MJ, Aranda P.
    Nefrologia; 2005 Jun 25; 25(4):387-92. PubMed ID: 16231504
    [Abstract] [Full Text] [Related]

  • 14. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
    Kang Z, Li Z, Duan C, Wu T, Xun M, Ding Y, Zhang Y, Zhang L, Yin Y.
    Pediatr Nephrol; 2015 Jul 25; 30(7):1121-9. PubMed ID: 25773534
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate Mofetil: A Possible Alternative Treatment for IgA Nephropathy.
    Baraldi O, Comai G, Cuna V, Cappuccilli M, Serra C, Ronco C, La Manna G.
    Contrib Nephrol; 2017 Jul 25; 190():108-116. PubMed ID: 28535523
    [Abstract] [Full Text] [Related]

  • 16. Retrospective study of mycophenolate mofetil treatment in IgA nephropathy with proliferative pathological phenotype.
    Liang Y, Zhang J, Liu D, Quan S, Xing G, Liu Z.
    Chin Med J (Engl); 2014 Jul 25; 127(1):102-8. PubMed ID: 24384432
    [Abstract] [Full Text] [Related]

  • 17. Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy.
    Tang S, Leung JC, Chan LY, Lui YH, Tang CS, Kan CH, Ho YW, Lai KN.
    Kidney Int; 2005 Aug 25; 68(2):802-12. PubMed ID: 16014059
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunosuppressive agents in the treatment of IgA nephropathy: A meta-analysis of clinical randomized controlled literature.
    Zheng J, Gong X, Wu Z.
    Niger J Clin Pract; 2020 Apr 25; 23(4):437-449. PubMed ID: 32246648
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of immunosuppressive therapies in the treatment of high-risk IgA nephropathy: A network meta-analysis.
    Liu T, Wang Y, Mao H, Yang L, Zhan Y.
    Medicine (Baltimore); 2021 Feb 26; 100(8):e24541. PubMed ID: 33663060
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.